Inhibition of nitric oxide synthase does not affect survival in a rat model of abdominal sepsis

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 57, Issue 2, 1997, Pages 105-109

  Strand, O A ^a,b   Kirkeboen K A ^a   Giercksky, K E ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

aminoethyl isothiourea; bacterial infections; monomethylarginine; septic shock; septicaemia; treatment outcome

Indexed keywords

AMINOETHYLISOTHIOURONIUM; LIPOPOLYSACCHARIDE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEPSIS; SURVIVAL;

ANIMALIA; BACTERIA (MICROORGANISMS); RATTUS NORVEGICUS;

EID: 0030905770     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365519709056377     Document Type: Article

References (35)

1. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-42.
2. Thiemermann C, Vane J. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccaride in the rat in vivo. Eur J Pharmacol 1990; 182: 591-5.
3. Nava E, Palmer RMJ, Moncada S. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? Lancet 1991; 338: 1555-7.
4. Kilbourne RG, Jubran A, Gross SS, Griffith OW, Levi R, Adams J, Lodato RF. Reversal of endotoxin mediated shock by N-g-monomethyl-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 1990; 172: 1132-8.
5. Robertson FM, Offner PJ, Ciceri DP, Becker WK, Pruitt Jr BA. Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock. Arch Surg 1994; 129: 149-56.
6. Kilbourne RG, Gross SS, Lodato RF, Adams J, Levi R, Miller LL, et al. Inhibition of interleukin-1-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1-alfa induced hypotension by N-omega-amino-L-arginine. J Natl Cancer Inst 1992; 84: 1008-16.
7. Petros A, Bennett D, Vallance P. Effect of nitric oxide synthase inhibitors in patients with septic shock. Lancet 1991; 338: 1557-8.
8. Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P. Effects of nitric oxide synthase inhibitors in humans with septic shock. Cardiovasc Res 1994; 28: 34-9.
9. Billar TR, Curran RD, Harbrecht BJ, Stuehr DJ, Demetris AJ, Simmons RL. Modulation of nitric oxide synthesis in vivo: N-g-monomethyl-1-arginine inhibits endotoxin-induced nitrite/nitrate biosynthesis while promoting hepatic damage. J Leu Biol 1990; 48: 565-9.
10. Nava E, Palmer RMJ, Moncada S. The role of nitric oxide in endotoxin shock: effects of L-NMMA. J Cardiovasc Pharmacol 1992; 20 Suppl 12: S132-4.
11. Hutcheson IR, Whittle BJ, Boughton-Smith NK. Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br J Pharmacol 1990; 101: 815-20.
12. Shultz P, Raji L. Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest 1992; 90: 1718-25.
13. Lundblad R, Giercksky K-E. The effect of volume support, antibiotic therapy and monoclonal anti-endotoxin antibodies on mortality and blood concentration of endothelin and other mediators in fulminant intra-abdominal sepsis in rats. Crit Care Med 1995; 23: 1382-90.
14. Brandtzæg P, Kierulf P, Gaustad P, Skulberg A, Bruun JB, Halvorsen S, et al. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Inf Dis 1989; 159: 195-204.
15. Casey L, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Int Med 1993; 119: 771-8.
16. Lowry SF. Sepsis and its complications: clinical definitions and therapeutic prospects. Crit Care Med 1994; 22: S1-2.
17. Teale DM, Atkinson AM. Inhibition of nitric oxide synthesis improves survival in a murine peritonitis model of sepsis that is not cured by antibiotics alone. J Antimicrob Chemother 1992; 30: 839-42.
18. Evans T, Carpenter A, Silva A, Cohen J. Inhibition of nitric oxide synthase in experimental gram-negative sepsis. J Infect Dis 1994; 169: 343-9.
19. Szabó C, Southan GJ, Thiemermann C. Beneficial effects and improved survival in a rodent model of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci (USA) 1995; 91: 12472-6.
20. Southan GJ, Szabó C, Thiemermann C. Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br J Pharmacol 1995; 114: 510-16.
21. Noether G. Introduction to statistics: a nonparametric approach. 2nd ed., Boston, Massachusetts: Houghton Mifflin, 1976: 128-35.
22. Win NHH, Ishikawa T, Saito N, Kato M, Yokokura H, Watanabe Y, et al. A new and potent calmodulin antagonist, HF-2035, which inhibits vascular relaxation induced by nitric oxide synthase. Eur J Pharmacol 1996; 299: 119-26.
23. Griffiths MJD, Messent M, MacAllister RJ, Evans TW. Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br J Pharmacol. 1993; 110: 963-8.
24. MacAllister RJ, Whitley GST, Vallance P. Effects of guanidino and uremic compounds on nitric oxide pathways. Kidney Int 1994; 45: 737-42.
25. Ohru T, Yamauchi K, Sekizawa K, Ohrawara Y, Maeyama K, Sasaki M, et al. Histamine N-methyltransferase controls the contractile responses of guinea pig trachea to histamine. J Pharmacol Exp Ther 1992; 261: 1268-72.
26. Eaton JD, Stevens EJ, Tomlinson DR. Effects of aminoguanidine on prostacyclin release and interactions with L-NAME. Br J Pharmacol 1993; 108: 128P.
27. G-methyl-L-arginine, an inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotension. Crit Care Med 1995; 23: 1018-24.
28. G-methylarginine. Biochem Biophys Res Commun 1990; 170: 96-103.
29. G-nitro L-arginine methyl ester and other alkyl esters of arginine are muscarine receptor antagonists. Circ Res 1993; 72: 387-95.
30. Almedahl SM, Nordstrand K, Melby K, Østerud B, Giercksky K-E. Faecal peritonitis in the rat - an experimental model for evaluation of surgical and adjuvant therapies. Acta Chirurg Scand 1985; 151: 213-16.
31. Almedahl SM, Østerud B, Melby K, Giercksky K-E. Mononuclear phagocyte thromboplastin, bacterial counts and endotoxin levels in experimental endogenous gram negative sepsis. Acta Chirurg Scand 1986; 152: 351-5.
32. Lundblad R, Giercksky K-E. Endothelin concentrations in experimental sepsis: profiles of big endothelin and endothelin 1-21 in lethal peritonitis in rats. Eur J Surg 1995; 161: 9-16.
33. Lundblad R, Sandven P, Giercksky KE. The physical nature of large bowel perforation predicts severity of the subsequent inflammatory response. Shock 1995; 3: 455-61.
34. Lundblad R, Giercksky KE. The synergistic effects of E5, imipenem and volume support during fulminant intraabdominal sepsis in rats. J Infect Dis 1995; 172: 152-60.
35. Wright CE, Rees DD, Moncada S. The protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 1992; 26: 48-57.